Although this study demonstrates that miR-127 also downregulates other genes that are overexpressed in cancer, such as FOXO6, SOX11, SOX12, and FASN, it provides the first example that targeting NANOS1 could be a potential cancer treatment strategy. Here, FASN is linked to cancer.